Brewin Dolphin Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-143
Closed -$35.6K 336
2021
Q1
$35.6K Buy
+143
New +$34.1K 0.01% 207
2020
Q4
Sell
-144
Closed -$36.6K 281
2020
Q3
$36.6K Buy
144
+30
+26% +$7.43K 0.01% 181
2020
Q2
$26.9K Buy
+114
New +$26K 0.01% 191

Other funds holding AMGN

Brewin Dolphin Wealth Management's AMGN Position: Q2 2021 in Review

Brewin Dolphin Wealth Management sold out of Amgen (AMGN) in Q2 2021, closing a stake of 143 shares — an estimated $35.6K sold.

Brewin Dolphin Wealth Management first reported a position in AMGN in Q2 2020 and held it in 3 quarters. The position peaked at $36.6K in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Brewin Dolphin Wealth Management reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • Brewin Dolphin Wealth Management sold 143 Amgen shares in Q2 2021, an estimated $35.6K.
  • Brewin Dolphin Wealth Management first reported a position in Amgen in Q2 2020 and held it in 3 quarters.
  • Brewin Dolphin Wealth Management's Amgen position peaked at $36.6K in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2021, filed 9 Nov 2023.